Opportunity Information: Apply for PA 20 190

The NIH Mentored Research Scientist Development Award (K01) is a career development grant designed to help early-stage or transitioning researchers build the skills, publication record, and scientific direction needed to become independent investigators. Through this program, NIH provides three to five years of support and protected time so an applicant can pursue an intensive, supervised research and training plan under experienced mentorship. The overall goal is to accelerate a candidate toward research independence in the biomedical, behavioral, or clinical sciences by combining a structured career development plan with a focused research project that strengthens the applicant's long-term trajectory.

A key feature of this specific parent announcement is reflected in its title: "Independent Clinical Trial Not Allowed." That means applicants cannot propose to lead an independent clinical trial as part of the K01-supported research. The award is meant to emphasize mentored development and research growth rather than independent trial leadership. Depending on NIH Institute and Center policies, candidates may still be able to gain clinical research experience in other ways, but the core K01 project under this FOA cannot be an independent clinical trial led by the K01 awardee.

NIH Institutes and Centers generally use the K01 mechanism to support mentored experiences that lead to independence, but the announcement also notes that some participating Institutes and Centers use K01 awards for specific situations. For example, certain ICs may prioritize applicants who are retraining into a new research area (such as moving from one discipline to another) or applicants who are restarting their research careers after a significant hiatus due to illness or major family responsibilities. The description also clarifies that some NIH components offer separate K01 funding opportunities specifically aimed at enhancing research workforce diversity, meaning applicants should pay attention to Institute-specific offerings in addition to this parent FOA.

Eligibility for applicant organizations is broad and includes many types of U.S.-based entities. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofit organizations (both with and without 501(c)(3) status) that are not institutions of higher education; for-profit organizations (other than small businesses); small businesses; and other organizations that meet NIH eligibility rules. The announcement explicitly highlights additional eligible categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments other than federally recognized ones, and U.S. territories or possessions.

Foreign and non-U.S. organizational participation is limited in specific ways. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, the announcement allows "foreign components" as defined by the NIH Grants Policy Statement. In practical terms, that typically means a U.S. applicant organization may include certain well-justified international collaborations or elements within the project, provided they meet NIH policy requirements and are appropriately described and approved.

Administratively, this opportunity is run by the National Institutes of Health and is a discretionary grant program under the funding instrument type "Grant," with activity categories tied to education and health. The funding opportunity title is "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)" and the funding opportunity number is PA-20-190. The original posting/creation date is May 7, 2020, and the source information lists an original closing date of May 7, 2024. The opportunity is associated with multiple CFDA numbers (now often referred to through Assistance Listing numbers), reflecting that many NIH Institutes and Centers participate and fund K01 awards through different NIH funding lines.

Overall, this K01 parent announcement is best understood as a structured mentored pathway: it pays for time and development so a candidate can deepen expertise, expand technical and conceptual skills, and produce strong research outputs under mentorship, with the end point being readiness to compete successfully for independent research funding. The most important constraints to keep in mind are the mentored nature of the award, the three-to-five-year protected-time expectation, and the explicit restriction that the proposed work cannot be an independent clinical trial led by the K01 awardee.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.351, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.866.
  • This funding opportunity was created on 2020-05-07.
  • Applicants must submit their applications by 2024-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 20 190

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) (PA-20-190)

What is the NIH Mentored Research Scientist Development Award (K01)?

The NIH K01 is a mentored career development grant intended to help early-stage or transitioning researchers build the skills, publication record, and scientific direction needed to become independent investigators. It supports an intensive, supervised research and training plan carried out under experienced mentorship.

What is the main purpose of this K01 parent opportunity?

The purpose is to accelerate a candidate toward research independence in the biomedical, behavioral, or clinical sciences by combining a structured career development plan with a focused research project that strengthens the applicant's long-term trajectory.

How long does the K01 provide support?

This K01 provides three to five years of support.

What does "protected time" mean in the context of this K01?

The opportunity describes providing protected time so the applicant can pursue an intensive mentored research and training plan. In practice, the emphasis is that the award supports dedicated time for supervised development and research growth as part of the candidate's pathway to independence.

What does "Independent Clinical Trial Not Allowed" mean?

It means the K01-supported research project under this funding opportunity cannot propose that the K01 awardee will lead an independent clinical trial. The award is intended to emphasize mentored development and research growth rather than independent clinical trial leadership by the candidate.

Can a K01 applicant get clinical research experience under this announcement?

The announcement notes that, depending on NIH Institute and Center policies, candidates may still be able to gain clinical research experience in other ways. However, the core K01 project under this FOA cannot be an independent clinical trial led by the K01 awardee.

Is this K01 focused more on mentorship or on running a major project independently?

This K01 is explicitly mentored. Its focus is a supervised research and training plan under experienced mentorship, with the goal of strengthening the candidate's development toward later research independence.

Who is this K01 designed for?

It is designed for early-stage or transitioning researchers, including individuals building toward independence and, in some Institute and Center contexts, those retraining into a new research area or restarting their research careers after a significant hiatus due to illness or major family responsibilities.

Do all NIH Institutes and Centers use the K01 in the same way?

No. The announcement notes that NIH Institutes and Centers generally use the K01 mechanism to support mentored experiences that lead to independence, but some participating Institutes and Centers use K01 awards for specific situations (such as retraining or restarting a career after a hiatus).

Are there separate K01 opportunities related to workforce diversity?

Yes. The description notes that some NIH components offer separate K01 funding opportunities specifically aimed at enhancing research workforce diversity, so applicants should pay attention to Institute-specific offerings in addition to this parent FOA.

What kinds of organizations are eligible to apply?

Eligibility for applicant organizations is broad and includes many U.S.-based entities, such as state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status) that are not institutions of higher education; for-profit organizations (other than small businesses); small businesses; and other organizations that meet NIH eligibility rules.

Are minority-serving institutions and community-based organizations included in eligible applicants?

Yes. The announcement explicitly highlights additional eligible categories including Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments other than federally recognized ones, and U.S. territories or possessions.

Can a foreign (non-U.S.) institution apply as the applicant organization?

No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization.

Can a non-U.S. component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are also not eligible to apply as the applicant organization.

Are any international elements allowed in a K01 application under this announcement?

Yes. The announcement allows "foreign components" as defined by the NIH Grants Policy Statement. Practically, this typically means a U.S. applicant organization may include well-justified international collaborations or elements within the project if they meet NIH policy requirements and are appropriately described and approved.

Which federal agency runs this opportunity?

This opportunity is run by the National Institutes of Health (NIH).

What is the funding instrument type for this opportunity?

The funding instrument type is a discretionary grant program under the instrument type "Grant."

What is the funding opportunity title and number?

The title is "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)" and the funding opportunity number is PA-20-190.

When was this opportunity originally posted, and what closing date is listed?

The original posting/creation date is May 7, 2020, and the source information lists an original closing date of May 7, 2024.

What research areas does this K01 support?

The K01 supports development toward independence in the biomedical, behavioral, or clinical sciences.

What are the most important constraints or features to keep in mind for this K01?

The key features highlighted are: (1) it is a mentored award focused on supervised development, (2) it provides three to five years of support with an expectation of protected time for research and training, and (3) the proposed work cannot be an independent clinical trial led by the K01 awardee.

Does this opportunity involve multiple NIH funding lines?

Yes. The opportunity is associated with multiple CFDA numbers (now often referred to through Assistance Listing numbers), reflecting that many NIH Institutes and Centers participate and fund K01 awards through different NIH funding lines.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)

Previous opportunity: Building National Resilience in a context of Sub-Regional Insecurity

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 20 190

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 20 190) also looked into and applied for these:

Funding Opportunity
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) Apply for PA 20 208

Funding Number: PA 20 208
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) Apply for RFA DA 21 019

Funding Number: RFA DA 21 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Apply for PA 20 149

Funding Number: PA 20 149
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Apply for PA 20 151

Funding Number: PA 20 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) Apply for PAR 20 221

Funding Number: PAR 20 221
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 20 225

Funding Number: PAR 20 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) Apply for PAR 20 224

Funding Number: PAR 20 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional) Apply for RFA DA 21 013

Funding Number: RFA DA 21 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) Apply for RFA CA 20 039

Funding Number: RFA CA 20 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) Apply for RFA CA 20 038

Funding Number: RFA CA 20 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) Apply for RFA DA 21 009

Funding Number: RFA DA 21 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Regional Medical Libraries for the Network of the National Library of Medicine (UG4) Apply for RFA LM 20 001

Funding Number: RFA LM 20 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 241

Funding Number: PAR 20 241
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) Apply for RFA CA 20 042

Funding Number: RFA CA 20 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) Apply for RFA DA 21 024

Funding Number: RFA DA 21 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Apply for PAR 20 249

Funding Number: PAR 20 249
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Network of the National Library of Medicine Evaluation Center (U24) (Clinical Trial Not Allowed) Apply for RFA LM 20 002

Funding Number: RFA LM 20 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $610,000
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 040

Funding Number: RFA CA 20 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) Apply for RFA CA 20 037

Funding Number: RFA CA 20 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed Apply for RFA DA 21 026

Funding Number: RFA DA 21 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 20 190", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: